Michelle Detwiler is a Managing Partner at Biospring Partners. Michelle has over 15 years of healthcare investment expertise at the Partner level. Michelle serves on the board of directors for Biospring portfolio companies Abzena, Cedar Health and CenExcel.
Michelle was previously a Managing Director at General Atlantic where she launched the firm’s life sciences investment platform. Prior to General Atlantic, Michelle was a Co-Founder and General Partner of Longwood Fund. Prior to Longwood, Michelle was the Senior Vice President of the CEEDD at GlaxoSmithKline (NASDAQ: GSK), leading global business development and M&A.
Michelle holds a Bachelor of Medicine and Bachelor of Surgery from the University of Oxford Medical School and a Doctor of Philosophy in Human Physiology from the University of Oxford.
CURRENT
FORMER
